Three port 20-gauge pars plana vitrectomy has been the gold standard for vitreoretinal surgery since 1974 [1] . Over the last decade, transconjunctival sutureless vitrectomy aiming to improve patient comfort has been introduced and has progressed dramatically. Transconjunctival sutureless vitrectomy was first succesfully performed by Fujii et al.
Since then, some investigators have reported results showing the effectiveness of the 23-gauge transconjunctival vitrectomy system for various vitreoretinal diseases. Transconjunctival 23-gauge vitrectomy provides potential advantages over traditional 20-gauge vitrectomy, including reduced conjunctival manipulation, increased patient comfort and recovery, faster wound healing, less conjunctival scarring, and reduced surgical time [13] [14] [15] [16] . Although some studies have compared the 23-gauge transconjunctival vitrectomy with the conventional 20-gauge vitrectomy [16] [17] [18] , there is limited number of published prospective studies [19, 20] .
Epiretinal membrane removal and vitrectomy accompanied with gas tamponade are the recognized treatments of choice for idiopathic epiretinal membranes (IERM) [21, 22] and macular holes (IMH) [23, 24] , respectively. Surgical techniques for both IMH and IERM are well described and consist of similar surgical manipulations. IERM and IMH patients undergoing vitrectomy surgery do not have noticeable individual anatomic differences that would affect surgical steps during vitrectomy and thus constitute homogeneous groups, making them suitable for comparison between the transconjunctival 23-gauge vitrectomy and conventional 20-gauge vitrectomy systems in terms of safety, complications, anatomic and functional success.
In this prospective study, our goal was to assess the safety and efficacy of 23-gauge transconjunctival vitrectomy compared with 20-gauge conventional pars plana vitrectomy in IERM and IMH surgeries.
Materials and Methods
A prospective clinical trial was designed to compare 20-and 23-gauge vitrectomy systems in a group of patients with IMH and IERM requiring uncomplicated macular surgery. Institutional review board approval was acquired, and signed informed consent was obtained from all participants in accordance with the Declaration of Helsinki. The patients were recruited consecutively to each group between July 2007 and April 2009. Inclusion criteria required that the patients present with grade 3 to 4 IMH [25] or grade 2 to 3 IERM [26] complaining of visual acuity decrement or metamorphopsia which negatively influenced quality of life. Any patients with additional ocular pathologies or ocular surface problems and patients who underwent an ocular surgery other than uncomplicated cataract surgery were excluded from the study.
In preoperative and postoperative examinations, all patients underwent best-corrected visual acuity (VA), applanation tonometry, as well as biomicroscopic anterior and posterior segment evaluation. Color fundus photographs and optical coherence tomography (OCT) examinations were performed before surgery and at postoperative visits. In the IERM patients, the central macular thickness (CMT) was measured using the macular thickness protocol of OCT (Zeiss-Humphrey Instruments, San Leandro, CA, USA). Postoperative visits were performed at 1 day, 1 week, 1 month, 3 months, every 3 months until 1 year, then every 6 months subsequently. Surgeries were performed by a single experienced surgeon (GG) at a single center.
Surgical technique
All patients underwent surgery with retrobulbar anesthesia. The periocular skin was prepared with 10% povidineiodine and 5% povidine-iodine solution instilled into the ocular surface and inferior fornix. Patients were draped, everting and covering lashes from the operative field. The vitrectomy system for all surgeries was the DORC Surgical System (Dutch Ophthalmic Research Center Inc., Zuidland, The Netherlands).
20-Gauge vitrectomy
The conjunctiva was opened in correspondence of the sclerotomy sites. Three scleral incisions were made 3.5 mm behind the limbus in the inferotemporal, superonasal, and superotemporal quadrants. The system was calibrated at 200 mmHg of vacuum and a cut rate of 2,500 per minute. After core vitrectomy, triamcinolone acetonide (Kenacort-A; Bristol-Myers-Squibb, Peapack, NJ, USA) was used to ensure that the posterior hyaloid was elevated, and total vitrectomy was performed in every case. Also, triamcinolone acetonide was used in epiretinal membrane cases to assist in membrane stripping and, in both macular hole and epiretinal membrane cases, to enhance internal limiting membrane removal. At the conclusion of each surgery, retinal breaks were checked, and peripheral vitrectomy was completed with scleral indentation under a wide-angle visualization system (EIBOS, Moller-Wedel, Germany). Endolaser photocoagulation was used to treat any retinal breaks. The sclerotomies were closed with 7-0 vicryl, and conjunctiva were closed with 8-0 vicryl suture.
23-Gauge vitrectomy
The two-step 23-gauge vitrectomy system was used as initially described by Eckardt [9] . The conjunctiva was displaced over the sclera to mismatch the conjunctival and scleral entry sites; three angled scleral tunnel incisions were made with an angled stiletto blade positioned at a 20° to 30° angle to the entry site, after which the sclera was entered with the trocars. The system was calibrated at 450 mmHg of vacuum and a cut rate of 1,500 per minute. The surgical procedures were performed as previously described for 20-gauge vitrectomy. At the end of the procedure, the infusion line was clamped, the superonasal cannula was removed, and the sclerotomy site was immediately massaged using a cotton swab. The infusion line was then unclamped, and the sclerotomy site was inspected for any leakage. The superotemporal cannula was removed in a similar fashion. If no leak was present, the inferotemporal cannula and the infusion line were removed. If any site demonstrated persistent leakage, 8-0 vicryl sutures were placed so as to bind the sclerotomy site with the overlying conjunctiva without opening the conjunctiva. Intraocular pressure (IOP) was measured at the end of the procedure.
A total gas or air fill was used in all IMH cases. All 23-gauge patients underwent partial f luid-air exchange filling at least 1 / 3 of the eye if a complete air-or gas-fluid exchange was not part of the intended procedure. All IMH patients maintained a prone position for 1 week postoperatively. Postoperative treatment for all patients consisted of lomefloxacin 0.3% and dexamethasone 0.5% eye drops applied topically 4 times daily for 2 weeks; treatment was modified at the postoperative visits.
For gradation of cataract formation, we used the Lens Opacities Classification System III assessing the lens opacification as grades 1 through 5. Grade 1 was classified as normal, grades 2 and 3 were classified as mild opacification, and grades 4 and 5 were classified as significant cataract and combined phacoemulsification. Intraocular lens implantation was performed on significant cataracts.
The surgical times were compared in the groups. The surgical opening time was defined as the interval between the first instrument contacting the conjunctiva and readiness for vitrectomy. The times required for vitrectomy and surgical manipulations were also evaluated separately. The closing time was defined as the interval between the end of manipulation and the removal of the lid speculum. Any intraoperative and postoperative complications, such as sclerotomy site wound leakage, hypotony, retinal tear, retinal detachment or endophthalmitis, were noted. Hypotony was defined as an IOP less than 6 mmHg during the postoperative assessment.
Surgical success was defined as closure of the macular hole for IMH patients and a decrease in CMT and an at least 3-month membrane-free postoperative period for IERM patients, which was determined by OCT. Snellen VA was converted into the logarithm of the minimum angle of resolution (logMAR) for statistical analysis. VA improvement was defined as the difference between preoperative and postoperative VA at the final postoperative visit. The postoperative ocular surface reaction was qualitatively graded by slit-lamp examination using a modified scale (Table 1) [19, 27] .
The primary outcome variables included primary anatomical success rate; postoperative VA improvement; intraoperative complications, such as the need for conversion to the 20-gauge system, dislodgement of the 23-gauge cannulas, and need for sclerotomy suture placement; and postoperative complications, such as wound leakage, hypotony, choroidal detachment, retinal detachment, cataract progression and endophthalmitis.
Statistical analysis
The differences between the patient groups were assessed for statistical significance using the Student's t-test, the Mann Whitney U-test, or chi-square test when appropriate. Statistical analysis was conducted using SPSS ver. 11.5 (SPSS Inc., Chicago, IL, USA), and p < 0.05 was considered statistically significant.
Result
Thirty-one eyes of 30 patients undergoing vitrectomy for IERM and IMH were recruited to the 20-gauge vitrectomy group and 33 eyes of 31 patients to the 23-gauge vitrectomy group. As shown in Table 2 , there were no statistically significant differences at baseline in patient characteristics, diagnoses, stage of diseases, preoperative lens status, or mean preoperative IOP value between the 20-and 23-gauge vitrectomy groups ( Table 2 ). The mean followup ± standard deviation (SD) was 12.8 ± 7.9 months in the 23-gauge group and 11.5 ± 4.2 months in the 20-gauge group ( p = 0.39).
Epiretinal membranes and/or internal limiting membranes were successfully removed from the fovea in all patients. For the IMH patients, the surgical success rate was 83.3% in the 20-gauge group and 90.9% in the 23-gauge group, with no significant difference ( p = 0.59). In the IERM patients, the surgical success rate was 100% for both groups. In the 20-gauge group, the tamponade media was gas (sulfur hexafluoride) in 12 eyes (38.7%), air in 10 eyes (32.2%), and fluid in 9 eyes (29%). Ten eyes (30.3%) in the 23-gauge group received gas (sulfur hexafluoride) tam- ponade. Among the remaining eyes, full air-fluid exchange was performed in 17 eyes (51.5%), and partial air-f luid exchange was performed in 6 eyes (18.1%). Concomitant phacoemulsification and posterior chamber intraocular lens implantation was performed for three eyes in the 20-gauge group and for one eye in the 23-gauge group.
In the 20-gauge group, the mean preoperative VA was 20 / 160. Mean postoperative acuities were 20 / 100 ( p = 0.002) at month 1, 20 / 72 ( p < 0.05) at month 3, 20 / 50 ( p < 0.05) at month 6, and 20 / 75 ( p < 0.05) at the final visit. In the 23-gauge group, the mean preoperative VA was 20 / 112. Mean postoperative acuities were 20 / 60 ( p < 0.05) at month 1, 20 / 60 ( p < 0.05) at month 3, 20 / 55 ( p = 0.01) at month 6, and 20 / 68 ( p < 0.05) at the final visit (Fig. 1) . In both groups of IERM or IMH, the VA improved significantly at 1 month postoperatively and at the final visit compared to preoperative results ( Fig. 2A and 2B ).
VA improvement was -0.32 ± 0.36 and -0.23 ± 0.32 log-MAR in the 20-and 23-gauge groups, respectively, and we did not observe a statistically significant difference with regard to VA improvement between the two groups ( p = 0.27).
The mean preoperative CMT value for the IERM patients was 373 ± 118 µ and 416 ± 164 µ in the 20-and 23-gauge groups, respectively. There were no statistically significant differences in the baseline mean CMT values between the 20-and 23-gauge vitrectomy groups (p = 0.42). In both groups, the mean CMT was significantly reduced at 1 month, 3 months, 6 months, and at the final postoperative visits compared with preoperative values ( p < 0.05) (Fig. 3) .
In The mean postoperative IOP ± SD on postoperative day 1 was 16.2 ± 3.9 mmHg in the 20-gauge group and 14.1 ± 2.2 mmHg in the 23-gauge group; the postoperative day 1 IOP in 23-gauge group was significantly lower than that of the 20-gauge group ( p = 0.01) (Fig. 4) . No patients in either group experienced hypotony on the first postoperative day, defined as an IOP less than 6 mmHg. An IOP less than 10 mm Hg was noted in 5 eyes (15.1%) in the 23-gauge group. Within the 20-gauge group, there were no significant differences at any visit when comparing with the preoperative values. In the 23-gauge group, the mean IOP on postoperative day 1 was significantly lower compared with the mean preoperative value (p = 0.04); however, this difference was not seen in other visits. Other than postoperative hypotony, eye pressure was observed to be greater than 22 mmHg in 5 eyes in the 20-gauge group and in no eyes in the 23-gauge group.
Ten (40%) of 25 phakic eyes in the 20-gauge group showed cataract progression within the postoperative period compared to 19 (65%) of 29 phakic eyes in the 23-gauge group ( p = 0.049). Cataract progression occurred at a mean of 7.7 ± 2.1 months after vitrectomy in the 20-gauge group versus 7.6 ± 2.7 months after vitrectomy in the 23-gauge group ( p = 0.89).
In the 20-gauge group, the mean postoperative ocular surface scores were 3.4 ± 1.1 at day 1, 3.2 ± 1.4 at week 1, and 2.67 ± 1.3 at month 1. In the 23-gauge group, the mean postoperative ocular surface scores were 1.2 ± 1.1 at 
Discussion
In the current study, the efficacy and the safety profile between 23-gauge transconjunctival vitrectomy and conventional 20-gauge vitrectomy were evaluated in patients with IMH and IERM who underwent macular surgery. The surgical outcomes observed after the 23-gauge vitrectomies were comparable with outcomes obtained after the conventional 20-gauge vitrectomies. For macular holes, the surgical success rate after one surgery was 83.3% in the 20-gauge group and 90.9% in the 23-gauge group ( p = 0.59), and both of these compare favorably with previously reported macular hole case series [16, 23, 28, 29] . Vitrectomy for ERM has become a standard and beneficial procedure with a very high success rate [21, 30] . The anatomical success rate was high, 100%, in both of our groups.
In both groups, statistically significant improvement in VA was achieved at 1 month postoperatively ( p = 0.002 for the 20-gauge group, p < 0.05 for the 23-gauge group) and thereafter at all postoperative visits ( p < 0.05) compared with preoperative VA. This has also been reported in other studies [13, 16, 17, 29] . Regarding postoperative VAs, the mean VA was higher 1 month postoperatively in the 23-gauge group than in the 20-gauge group ( p = 0.025); however, we did not see a significant difference between the two study groups 3 or 6 months postoperatively or at the final visit ( p = 0.81, p = 0.597, and p = 0.422, respectively). Additionally, Hikichi et al. [17] and Narayanan et al. [18] also reported that 23-gauge vitrectomy is associated with faster improvement in vision. We noted that visual gain after a 23-gauge vitrectomy is comparable with that after a conventional 20-gauge vitrectomy. Although not statistically significant, we noticed a decreased mean VA of both groups at the final visit; the underlying reason was believed to be cataract progression, which was observed at a rate of 40% in the 20-gauge group and 65% in the 23-gauge group. This compares well with published data. The most common complication of macular hole surgery in phakic eyes is cataract formation, with a reported rate of 30% to 50% [31, 32] . This rate is reported between 12% and 68% for patients who underwent epiretinal membrane surgery [33, 34] . In our study, a borderline significance for increased cataract progression was observed in the 23-gauge group, and this most likely related to performing partial fluid-air exchange even in patients who did not require a tamponade at the end of the surgical procedure, as well as to a greater number of patients in this group having lens opacity greater than grade 1. Although our sample size is too small to make a definitive conclusion, we think that this result is a consequence of partial fluid-air exchange at the end of surgery, rather than the 23-gauge vitrectomy system itself.
The popularity of transconjunctival sutureless vitrectomy has increased over the past years, one reason being the reduction of surgical duration. In some comparative interventional studies, the authors showed a significantly reduced operation duration using the 23-gauge system in various vitreoretinal diseases, but they did not document the amount of vitreous removed [17, 20, 35] . In contrast, in this study, the mean surgery time was 20 minutes 37 seconds in the 20-gauge group and 17 minutes 51 seconds in 23-gauge group. The latter seems to be shorter, but the difference was not found to be significant ( p = 0.90). However, we observed that the 23-gauge group showed a significantly shorter duration for opening time ( [19] found that the durations of wound opening and wound closure were significantly shorter and vitrectomy time was significantly longer with the 23-gauge system. They concluded that the time gain in wound opening and closure was equalized by a longer vitrectomy time when attempting to remove a similar amount of vitreous.
No technical difficulties occurred in our cases using the 23-gauge system during surgery, and all intraoperative maneuvers were feasible. No procedures required a switch to conventional 20-gauge sclerotomy. In 23-gauge vitrectomy, a tangential incision is made at a 20° to 30° angle through the sclera, so that suturing is not required due to the angled, self-sealing properties of the incision and the pressing effect of IOP [9, 10] . Performing partial fluid/air exchange at the completion of surgery has been recommended to create a temporary tamponade and aid in the closure of the ports [6, 29, 36] . In our series, 11 (15%) sclerotomy ports required suturing. The intraoperative suture rate among published 23-gauge studies ranges from 0% to 26% [13, 15, 16, 19] . The higher rate of wound suturing in the present series may reflect the confident attitude of the surgeon.
Postoperative hypotony due to leakage from sclerotomies is an important shortcoming in transconjunctival surgeries. The reported incidence of hypotony after a 23-gauge vitrectomy ranges from 0% to 21.1% (with hypotony defined as a pressure between 6 mmHg and 10 mmHg) [13] [14] [15] [16] [17] . We did not observe hypotony in any of the patients in either group throughout the follow-up period. During the first few postoperative days, the 23-gauge group showed more eyes with low pressure (<10 mmHg), but no hypotony was observed. The reason for this may be our high rate of sclerotomy suturing and partial fluid/air exchange at the end of surgery. These results are comparable to the reports of Eckardt [9] and Kim et al. [13] , who did not observe any hypotony after performing 23-gauge vitrectomies. In the 23-gauge group, the mean IOP on postoperative day 1 was significantly lower compared with the mean preoperative value ( p = 0.04); however, this difference was not observed at other postoperative visits. The mean first day IOP was significantly lower in the 23-gauge group compared with the 20-gauge group ( p = 0.01). In our surgeries, using gas tamponade and minimal fluid-air exchange at the end of the surgery, even in the cases not requiring a tamponade, might have prevented postoperative hypotony. This data confirms the protective role of gas tamponade and partial air exchange against postoperative hypotony [14, 36] . We had no severe complications related to hypotony, such as choroidal effusion or vitreous hemorrhage. The eye pressure was greater than 22 mmHg in 5 eyes in the 20-gauge group and none in the 23-gauge group. This data compares well with the report of Misra et al. [20] , in which they suggested that increased IOP (>40 mmHg) on postoperative day 1 is less likely with 23-gauge vitrectomy.
Sutureless sclerotomies present a theoretical increase in the risk of endophthalmitis, especially with 25-gauge surgery. We had no cases of endophthalmitis in either group. The risk of endophthalmitis after 20-gauge vitrectomy is rare, with an estimated incidence ranging from 0.039% to 0.07%; however, the risk of endophthalmitis in 23-gauge vitrectomy remains unclear, and there is limited information in the literature [10, [15] [16] [17] 19, 37, 38] . A large case series reported from the Wills Eye Institute showed an endophthalmitis rate of 0.23% (7 / 3,103 eyes) for 25-gauge vitrectomy, compared with only 0.018% (1 / 5,498 eyes) for 20-gauge vitrectomy, representing a 12-fold increased risk [39] . Recently, in a large retrospective case series, the incidence of endophthalmitis during the study period of 2007 to 2008 was 0.02% for 20-gauge compared with 0.03% for 23-gauge and 0.13% for 25-gauge vitrectomies [40] . There was no significant difference in endophthalmitis rates between any two of the three groups. Compared with the endophthalmitis rates among the same group of vitreoretinal surgeons during the previous 2 years, the endophthalmitis rates following 20-gauge and 23-gauge vitrectomy were stable, and the rate following 25-gauge vitrectomy was marginally lower. All these reports emphasized the importance of meticulous aseptic techniques, conjunctival wash-out with povidone-iodine, and misalignment of the conjunctival and scleral openings following removal of the cannulas.
The 23-gauge system permitted us to perform a complete vitrectomy and peripheral vitreous base cleaning. Two months postoperatively, one eye in the 20-gauge group presented with retinal detachment caused by a new retinal tear which did not correspond to the sclerotomies. Complications were rare and compared favorably with previously reported 23-gauge and 20-gauge series [17, 19, 20, 35] .
In our study, there was less postoperative ocular surface inf lammation and conjunctival scarring with 23-gauge vitrectomy compared with 20-gauge vitrectomy at all postoperative visits. A number of previously published studies reported that the clinical inflammation score was lower after transconjunctival 23-gauge vitrectomy compared with 20-gauge vitrectomy [17, 19] .
Our study has obvious limitations which are related to the relatively small number of cases and the lack of randomization in the prospective design. These create inadequacies for meaningful conclusions regarding the efficacy and safety of the 23-gauge transconjunctival vitrectomy system, especially in evaluating rare complications, such as endophthalmitis or retinal detachment. However, our promising results provide useful data to conduct further prospective, randomized, controlled clinical studies with larger sample sizes.
In our study, compared to conventional 20-gauge vitrectomy, the 23-gauge transconjunctival vitrectomy system appeared to be an equally safe and effective technique for the treatment of IMH and IERM without any major drawbacks. Although further large scale prospective studies are required, the 23-gauge vitrectomy system might be a favorable alternative to the 20-gauge vitrectomy system in macular surgery.
